Comparative effects of consuming various whole fruits before meals on fasting blood glucose and insulin levels among patients with type 2 diabetes mellitus in Indonesia
| ISRCTN | ISRCTN10024302 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN10024302 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Protocol serial number | Nil known |
| Sponsor | Sebelas Maret University |
| Funder | Ministry of Education, Culture, Research, and Technology (Kementrian Pendidikan, Kebudayaan, Riset dan Teknologi [Kemendikbudristek]), Republik Indonesia |
- Submission date
- 30/12/2021
- Registration date
- 20/01/2022
- Last edited
- 18/01/2022
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Plain English summary of protocol
Background and study aims
Type 2 diabetes is a common condition that causes the level of sugar (glucose) in the blood to become too high. The majority of patients with type 2 diabetes have low fibre intake especially from whole fruits. Previous studies have indicated that consumption of 50 g of Ambon banana before having breakfast reduces fasting blood glucose (FBG) in patients with type 2 diabetes and waist circumference in overweight adults. The aim of this study is to analyze the effects of eating whole fruits with low, medium and high glycemic indexes before meals on FBG and insulin levels in patients with type 2 diabetes.
Who can participate?
Patients aged 30–75 years old with type 2 diabetes
What does the study involve?
The participants are randomly divided into four groups. The first (control) group receive education on diabetes and diet on the first day of intervention and the day after 7 days wash out. The treatment (T) groups consisted of the T1, T2 and T3 groups. The T1 group receive the same diet education on the first day of the intervention and consume 250 g/day whole fruits with a low glycaemic index (Ambon banana, red apple, Asia pear, Malang orange or khalas date) after having breakfast, lunch and dinner with steamed rice, animal meats and or plant proteins, and mixed vegetables for 7 days. The T2 and T3 groups receive the same as the T1 group but the T2 group consume 250 g/day whole fruits with a moderate glycaemic index (California papaya, golek mango, honey pineapple, lady’s finger banana or longan) and the patients in the T3 group consume 250 g/day whole fruits with a high glycaemic index (ripe Ambon banana, red watermelon, melon or sapodilla). After that, all patients in the T1-3 groups go back to their normal eating habits for the next 7 days and the following day they begin to consume 250g/day whole fruits with a low, moderate or high glycaemic index before having breakfast, lunch and dinner with steamed rice, animal meats and or plant proteins, and mixed vegetables for 7 days.
What are the possible benefits and risks of participating?
The benefits to participants include:
1. Free tests
2. Free whole fruits
3. Knowing their daily energy and nutrition intake
4. Knowing their nutrition status and pancreas function
5. Reduced FBG
6. Increased insulin levels
The risks include:
1. Mild or moderate pain when giving blood samples
2. Food allergy
3. Discomfort in the stomach
Where is the study run from?
The four Health Clinics for the Management Program of Chronic Diseases (MTA, Mitra Sehat, Dr. Nurfanda and Persadia) in Surakarta city, Central Java Province (Indonesia)
When is the study starting and how long is it expected to run for?
October 2018 to March 2019
Who is funding the study?
Ministry of Education, Culture, Research, and Technology (Indonesia)
Who is the main contact?
1. Dono Indarto, dono@staff.uns.ac.id
2. Nuraini Fitri
Contact information
Principal investigator
Biomedical Laboratory
Faculty of Medicine
Universitas Sebelas Maret Surakarta
Jl. Ir. Sutami 36A Kentingan, Jebres
Surakarta
57126
Indonesia
 ORCID ID |
0000-0001-7420-5816 |
|---|---|
| Phone | +62 (0)271664178 |
| dono@staff.uns.ac.id |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomized controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Low-, medium and high glycaemic index fruits meal sequence randomized controlled trial among type 2 diabetes mellitus (T2DM) in Indonesia |
| Study objectives | 1. Meal sequence modification leads to improvement of the patients’ diabetic profile 2. Meal sequence modification by fruits with different glycemic indexes results in different diabetic responses |
| Ethics approval(s) | Approved 24/10/2018, Health Research Ethics Committee, Faculty of Medicine, Universitas Sebelas Maret (2nd Floor, Gedung Pendidikan Dokter, Jl. Ir. Sutami 36A, Kentingan, Surakarta 57126, Central Java, Indonesia; +62 (0)271 664178 ext. 125; kepk@fk.uns.ac.id), ref: 316/UN27.6/KEPK/2018 |
| Health condition(s) or problem(s) studied | Type 2 diabetes mellitus |
| Intervention | The researchers randomly chose four from 12 Health Clinics for Management Program of Chronic Diseases in Surakarta city, Central Java province which had sufficient patients with type 2 diabetes. To recruit the diabetes patients, they used a formula from Dahlan (2010) and the results of a previous study performed by Trico et al. (2016) to obtain 9 patients/group and added 30% patients/group to avoid loss of follow up. The patients were randomly divided into four groups. The first (control) group consisted of 12 patients who received education on diabetes and diet on the first day of intervention and the day after 7 days wash out. The treatment (T) groups consisted of the T1, T2 and T3 groups, which had 12, 12 and 11 patients with type 2 diabetes, respectively. The T1 group received the same diet education on the first day of the intervention and consumed 250 g/day whole fruits with low glycaemic index (Ambon banana, red apple, Asia pear, Malang orange or khalas date) after having breakfast, lunch and dinner with steamed rice, animal meats and or plant proteins, and mixed vegetables for 7 days. The T2 and T3 groups received the same as the T1 group did but the patients in the T2 group consumed 250 g/day whole fruits with moderate glycaemic index (California papaya, golek mango, honey pineapple, lady’s finger banana or longan) and the patients in the T3 group consumed 250 g/day whole fruits with high glycaemic index (ripe Ambon banana, red watermelon, melon or sapodilla). After that, all patients in the T1-3 groups were back to their eating habits for the next 7 days and the following day they began to consume 250g/day whole fruits with a low, moderate or high glycaemic index before having breakfast, lunch and dinner with steamed rice, animal meats and or plant proteins, and mixed vegetables for 7 days. |
| Intervention type | Behavioural |
| Primary outcome measure(s) |
1. Fasting blood glucose (FBG) levels measured using the enzymatic method (glucose oxidase – peroxidase aminoantypirin) at 1, 7, 14 and 21 days |
| Key secondary outcome measure(s) |
1. Basic characteristics including age, gender, marital status, education, job, food allergy, duration of type 2 diabetes illness, and type of oral antidiabetic drugs, collected using open questionnaires consisting of short questions 1 week before the research commenced. |
| Completion date | 20/03/2019 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 48 |
| Total final enrolment | 47 |
| Key inclusion criteria | 1. Aged 30–75 years old 2. Routinely treated by anti-diabetic drugs except for DPP4 inhibitor 3. Able to ingest fresh fruits |
| Key exclusion criteria | 1. Pregnant 2. Smoking 3. Chronic disease (e.g. heart, kidney, liver disease) 4. Insulin and DPP4 inhibitor therapy 5. Not routinely visiting the clinics |
| Date of first enrolment | 01/11/2018 |
| Date of final enrolment | 15/12/2018 |
Locations
Countries of recruitment
- Indonesia
Study participating centres
Surakarta
57191
Indonesia
Surakarta
57127
Indonesia
Sukoharjo
57166
Indonesia
Surakarta
57126
Indonesia
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | Patient data are kept confidential. Therefore, data requests need to be sent to Dono Indarto (dono@staff.uns.ac.id) and the Research Ethical Committee, Faculty of Medicine, Universitas Sebelas Maret/Public Hospital Dr Moewardi, Surakarta. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
17/01/2022: Trial's existence confirmed by Universitas Sebelas Maret.
